106 related articles for article (PubMed ID: 10987436)
1. N1-Arylsulfonyl-N2-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor.
Dauban P; Ferry S; Faure H; Ruat M; Dodd RH
Bioorg Med Chem Lett; 2000 Sep; 10(17):2001-4. PubMed ID: 10987436
[TBL] [Abstract][Full Text] [Related]
2. N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor.
Kessler A; Faure H; Petrel C; Ruat M; Dauban P; Dodd RH
Bioorg Med Chem Lett; 2004 Jun; 14(12):3345-9. PubMed ID: 15149704
[TBL] [Abstract][Full Text] [Related]
3. N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.
Kessler A; Faure H; Petrel C; Rognan D; Césario M; Ruat M; Dauban P; Dodd RH
J Med Chem; 2006 Aug; 49(17):5119-28. PubMed ID: 16913701
[TBL] [Abstract][Full Text] [Related]
4. N(1)-Arylsulfonyl-N(2)-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor.
Kessler A; Faure H; Roussanne MC; Ferry S; Ruat M; Dauban P; Dodd RH
Chembiochem; 2004 Aug; 5(8):1131-6. PubMed ID: 15300839
[No Abstract] [Full Text] [Related]
5. Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary tumor cells.
Ferry S; Chatel B; Dodd RH; Lair C; Gully D; Maffrand JP; Ruat M
Biochem Biophys Res Commun; 1997 Sep; 238(3):866-73. PubMed ID: 9325183
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor.
Coulombe J; Faure H; Robin B; Ruat M
Biochem Biophys Res Commun; 2004 Oct; 323(4):1184-90. PubMed ID: 15451421
[TBL] [Abstract][Full Text] [Related]
8. Developmental and adult expression of rat calcium-sensing receptor transcripts in neurons and oligodendrocytes.
Ferry S; Traiffort E; Stinnakre J; Ruat M
Eur J Neurosci; 2000 Mar; 12(3):872-84. PubMed ID: 10762317
[TBL] [Abstract][Full Text] [Related]
9. Aluminum is a weak agonist for the calcium-sensing receptor.
Spurney RF; Pi M; Flannery P; Quarles LD
Kidney Int; 1999 May; 55(5):1750-8. PubMed ID: 10231437
[TBL] [Abstract][Full Text] [Related]
10. Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor.
Lu JY; Yang Y; Gnacadja G; Christopoulos A; Reagan JD
J Pharmacol Exp Ther; 2009 Dec; 331(3):775-86. PubMed ID: 19759318
[TBL] [Abstract][Full Text] [Related]
11. Cloned and expressed rat Ca2+-sensing receptor.
Ruat M; Snowman AM; Hester LD; Snyder SH
J Biol Chem; 1996 Mar; 271(11):5972-5. PubMed ID: 8626377
[TBL] [Abstract][Full Text] [Related]
12. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action.
Hénaut L; Boudot C; Massy ZA; Lopez-Fernandez I; Dupont S; Mary A; Drüeke TB; Kamel S; Brazier M; Mentaverri R
Cardiovasc Res; 2014 Feb; 101(2):256-65. PubMed ID: 24217682
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells.
Dickenson JM; Hill SJ
Eur J Pharmacol; 1996 Apr; 302(1-3):141-51. PubMed ID: 8791002
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cell proliferation by calcium and a calcimimetic compound.
Mailland M; Waelchli R; Ruat M; Boddeke HG; Seuwen K
Endocrinology; 1997 Sep; 138(9):3601-5. PubMed ID: 9275041
[TBL] [Abstract][Full Text] [Related]
15. [Calcimimetic agents in the treatment of hyperparathyroidism secondary to chronic renal failure].
Negri AL; Slatopolsky EA
Medicina (B Aires); 2003; 63(2):165-71. PubMed ID: 12793088
[TBL] [Abstract][Full Text] [Related]
16. Calcimimetics and hyperparathyroidism.
Krebs LJ
Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
[TBL] [Abstract][Full Text] [Related]
17. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
[TBL] [Abstract][Full Text] [Related]
18. Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor.
Garcia M; Sakamoto K; Shigekawa M; Nakanishi S; Ito S
Biochem Pharmacol; 1994 Nov; 48(9):1735-41. PubMed ID: 7526867
[TBL] [Abstract][Full Text] [Related]
19. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells.
Kanatani M; Sugimoto T; Kanzawa M; Yano S; Chihara K
Biochem Biophys Res Commun; 1999 Jul; 261(1):144-8. PubMed ID: 10405337
[TBL] [Abstract][Full Text] [Related]
20. Formation of inositol phosphates in synaptoneurosomes of guinea pig brain: stimulatory effects of receptor agonists, sodium channel agents and sodium and calcium ionophores.
Gusovsky F; Daly JW
Neuropharmacology; 1988 Jan; 27(1):95-105. PubMed ID: 2451187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
